Strides Pharma Science Limited (NSE:STAR)
898.75
+11.40 (1.28%)
Jun 27, 2025, 3:29 PM IST
Strides Pharma Science Revenue
In the fiscal year ending March 31, 2025, Strides Pharma Science had annual revenue of 45.65B INR with 12.69% growth. Strides Pharma Science had revenue of 11.90B in the quarter ending March 31, 2025, with 9.81% growth.
Revenue
45.65B
Revenue Growth
+12.69%
P/S Ratio
1.81
Revenue / Employee
14.90M
Employees
3,065
Market Cap
82.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 45.65B | 5.14B | 12.69% |
Mar 31, 2024 | 40.51B | 3.63B | 9.83% |
Mar 31, 2023 | 36.88B | 6.18B | 20.13% |
Mar 31, 2022 | 30.70B | -2.46B | -7.41% |
Mar 31, 2021 | 33.16B | 5.64B | 20.49% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.83B |
Strides Pharma Science News
- 2 months ago - Strides Pharma receives USFDA approval for Celecoxib Capsules - Business Upturn
- 2 months ago - Strides Pharma incorporates new subsidiary ‘Pivot Path’ to boost life sciences and digital innovation - Business Upturn
- 5 months ago - Strides Pharma shares surge 5% as revenue jumps 15% YoY in Q3 FY25 - Business Upturn
- 5 months ago - Strides Pharma Q3 FY25 Results: Revenue up 15% YoY to Rs 1,154 crore, Net Profit up 60% YoY - Business Upturn
- 5 months ago - Strides Pharma receives USFDA approval for acetaminophen and ibuprofen tablets, expanding OTC portfolio - Business Upturn
- 8 months ago - Strides Pharma Science Q2 FY25 Results: Net profit surges to ₹93.7 crore, US revenues hit historic high - Business Upturn
- 9 months ago - OneSource raises Rs 801 crore from investors, boosts growth for Strides shareholders - Business Upturn
- 10 months ago - Strides Pharma shares surge 3% on USFDA nod for Fluoxetine Tabs 60 mg - Business Upturn